Unichem Laboratories GST appeal: ₹87.07 cr penalty order

What the Thane GST appellate order says

Unichem Laboratories Limited has received an Order-in-Appeal from the Commissioner (Appeals), Thane, dated September 18, 2026. The matter relates to GST liabilities linked to the cross-charge of common services. Disclosures and reports around the order describe a penalty of ₹87.07 crore and an interest component of about ₹6.58-₹6.59 crore. The penalty has been referenced under Section 74(1) and Section 122(2)(b) of the CGST Act, 2017, along with corresponding provisions under the Maharashtra SGST Act, 2017. The interest element has been described as being for delayed payment of tax liabilities. Unichem has said it plans to challenge the order further, within prescribed timelines. The company has also stated it does not expect any material operational or financial impact from the dispute.

Why the dispute arose: cross-charge of common services

The dispute has been linked to tax liabilities on cross-charge services within the organisation. In GST terms, cross-charge commonly arises when shared services are allocated between registrations or units, creating an internal service transaction for tax purposes. In this case, the filings referenced allegations around delayed tax payments and non-payment of interest. The legal references mentioned include Section 13 of the CGST Act, 2017, and Rule 47 of the CGST Rules, 2017, in addition to the penalty provisions. While the detailed reasoning in the appellate order is not provided in the available text, the stated subject matter is consistent across summaries. The quantum involved is large enough to be material in absolute terms, even as the company has said it does not expect material impact. The dispute sits in the broader category of GST classification, valuation, and procedural compliance issues that companies sometimes face in inter-unit allocations. Unichem has framed its next step as a further appeal based on legal advice.

Key amounts involved (normalised to ₹ crore)

The disclosed numbers in reports are presented in different formats and, in one place, with a small variation in the interest figure. The penalty figure is consistently stated as ₹87.07 crore. The interest figure is stated as ₹6.59 crore in one summary and ₹6.58 crore in another.

Procedural history: from assessment to Order-in-Appeal

The Order-in-Appeal relates to Unichem’s appeal against an assessment order originally received on January 24, 2025. The Commissioner (Appeals), Thane, has been described as disallowing the company’s appeal against that assessment order. Separately, one report used language that the penalty and interest were “disallowed” in the appeal instance, creating ambiguity in secondary summaries. However, multiple references in the provided text describe the order as adverse and as confirming the penalty and interest. Given the company’s stated intent to pursue a further appeal, the matter appears to remain open in the litigation cycle. The company has said it will file the next appeal within prescribed timelines. The disclosure was made under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. For investors, the key takeaway is that the order has been formally communicated and the company has set out its intended legal response.

Company response and expected impact

Unichem’s management has stated that it expects no material impact on financial, operational, or other business activities. The company has also said it plans to challenge the Order-in-Appeal through a further appeal. The wording indicates the company is acting on legal advice and intends to follow the timeline available under the applicable rules. No payment plan, deposit details, or provisioning commentary is provided in the text shared. The company’s stance is important because it frames the issue as manageable from an operational continuity perspective. At the same time, the penalty and interest amounts are sizable in absolute terms. Investors typically monitor whether such disputes lead to cash outflows, changes in contingent liability disclosures, or shifts in compliance posture. The company’s exchange filing route suggests it is treating the development as a regulatory disclosure event.

How the news flow can be read by markets

Tax litigation updates often affect sentiment based on two factors: the size of the exposure and the perceived probability of cash outflow. Here, the exposure cited is ₹87.07 crore plus interest of about ₹6.58-₹6.59 crore. But the company has said it does not expect material impact, and it is pursuing further appellate remedies. The market may also focus on the nature of the issue: cross-charge of common services can be a technical area with interpretational differences. Another point is the consistency of reporting language, as one summary mentions “confirming” while another uses “disallowing” in relation to the penalty and interest, which can confuse quick reads. In such cases, investors generally rely on the company’s official exchange filing and the actual order text where available. What is clear from the disclosed information is that the matter is being contested and has not been treated as business-disruptive by management.

Related GST litigation: the Dehradun TRAN-1 credit order

Unichem has also disclosed a separate GST appellate development from Dehradun. The company said it received an order on July 28, 2026 from the Additional Commissioner, CGST (Appeals), Dehradun. That appeal related to the disallowance of GSTR TRAN-1 credit of ₹0.73 crore (₹73.03 lakh) under Section 140(3) of the CGST Act, 2017. Following the appeal, the revised demand was stated at ₹0.11 crore (₹10,59,354) plus interest under Section 50 of the CGST Act. The company said this order too was not expected to have a material impact, and it planned to take appropriate steps, including filing an appeal within prescribed timelines. This parallel disclosure shows that multiple GST matters are being handled through the appellate route. It also shows the company’s consistent approach of contesting adverse elements while communicating expected impact.

Timeline of disclosed GST matters

The dates and actions below are limited to what is stated in the provided text.

Why this development matters

For Unichem, the key issue is the size of the Thane exposure and the legal classification of cross-charge services under GST. The cited penalty provisions, Sections 74(1) and 122(2)(b), are typically associated with more serious alleged contraventions, which can raise attention even when contested. The presence of a separate interest element indicates the dispute also covers timing and procedural aspects of tax payment. From a compliance perspective, GST disputes over internal allocations can influence documentation practices, invoicing between registrations, and interest computations. For investors, the most actionable disclosures at this stage are the quantified amounts, the appellate posture, and management’s statement of no material impact. The next concrete milestone is the filing of the further appeal within the prescribed timeline, as stated by the company.

Conclusion

Unichem Laboratories has disclosed an Order-in-Appeal from the Commissioner (Appeals), Thane dated September 18, 2026, involving a ₹87.07 crore GST penalty and about ₹6.58-₹6.59 crore of interest linked to cross-charge services. The company has said it will challenge the order through a further appeal within prescribed timelines and expects no material impact on operations or finances. Investors will likely track future updates tied to the next appeal stage and any subsequent disclosures under SEBI’s listing regulations.